Tournament: Greenhill | Round: 1 | Opponent: McNeil AG | Judge: Eric He
Wills, MBA, and Lipkus, PhD, 20 – Todd J. Wills ~Managing Director @ Chemical Abstracts Service, MBA from THE Ohio State University~ and Alan H. Lipkus ~Senior Data Analyst @ Chemical Abstracts Service, PhD Physical Chemistry from the University of Rochester~, "Structural Approach to Assessing the Innovativeness of New Drugs Finds Accelerating Rate of Innovation," ACS Medicinal Chemistry Letters, Vol. 11, 2020, https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.0c00319 C.VC
Despite recent concerns over an innovation crisis, this analysis shows pharmaceutical innovation has actually
AND
never been used as the basis for a molecule) to further explore.
Kristina M. Lybecker, PhD, 17 ~PhD Economics, Associate Professor of Economics @ Colorado College~, "Intellectual Property Rights Protection and the Biopharmaceutical Industry: How Canada Measures Up," Fraser Institute, January 2017, https://www.fraserinstitute.org/sites/default/files/intellectual-property-rights-protection-and-the20biopharmaceutical-industry.pdf C.VC
The unique structure of the innovative biopharmaceutical industry necessitates a variety of intellectual property protection
AND
shaping the biopharmaceutical industry, its profitability, productivity, and innovative future.
Eiland 08 ~Dr. Eiland received a doctorate in Oriental Archaeology from Oxford University and an LLM from the Munich Intellectual Property Law Center~, "Patenting Traditional Medicine", Nomos Verlagsgesellschaft mbH and Co. KG, pg. 7-10, 2008 SLC PK
TM = traditional medicine
In 1982, it was estimated that about 50
AND
natural substances, as well as the knowledge about how to use them.
Pharmaceutical innovation is key to protecting against future pandemics, bioterrorism, and antibiotic resistance.
Marjanovic and Fejiao '20 Marjanovic, Sonja, and Carolina Feijao. Sonja Marjanovic, Ph.D., Judge Business School, University of Cambridge. Carolina Feijao, Ph.D. in biochemistry, University of Cambridge; M.Sc. in quantitive biology, Imperial College London; B.Sc. in biology, University of Lisbon. "Pharmaceutical Innovation for Infectious Disease Management: From Troubleshooting to Sustainable Models of Engagement." (2020). ~Quality Control~
As key actors in the healthcare innovation landscape, pharmaceutical and life sci-ences
AND
health threats to an even greater extent under improved innova-tion conditions.
Bioterrorism and future pandemics cause extinction.
Hamish De Bretton-Gordon, CBRN Expert @ British Army, 20 ~Director @ DBG Defense, Consultant on CBRN and Biosecurity~, "Biosecurity in the Wake of COVID-19: The Urgent Action Needed," Combatting Terrorism Center Sentinel, November/December 2020, Volume 13, Issue 11, https://ctc.usma.edu/biosecurity-in-the-wake-of-covid-19-the-urgent-action-needed/ C.VC
Policymakers around the world did not grasp just how large the impact of a bio
AND
forward, there should no higher priority for the international community than biosecurity.